EP1549951A4 - Proteines de type semaphorine et methodes d'utilisation de celles-ci - Google Patents

Proteines de type semaphorine et methodes d'utilisation de celles-ci

Info

Publication number: EP1549951A4
Authority: EP; European Patent Office
Prior art keywords: semaphorin; proteins; methods; same
Prior art date: 2002-05-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP03739026A

Other languages

German (de)

English (en)

Other versions

EP1549951A2 (fr

Inventor

Enrique Alvarez

David W Anderson

Mohanraj Dhanabal

Nikolai V Khramtsov

William J Larochelle

Henri S Lichenstein

Li Li

Chean Eng Ooi

Muralidhara Padigaru

Richard A Shimkets

Mei Zhong

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

CuraGen Corp

Original Assignee

CuraGen Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-30

Filing date

2003-05-30

Publication date

2006-08-09

2003-03-31 Priority claimed from US10/403,676 external-priority patent/US20040029150A1/en

2003-05-30 Application filed by CuraGen Corp filed Critical CuraGen Corp

2005-07-06 Publication of EP1549951A2 publication Critical patent/EP1549951A2/fr

2006-08-09 Publication of EP1549951A4 publication Critical patent/EP1549951A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

EP03739026A 2002-05-30 2003-05-30 Proteines de type semaphorine et methodes d'utilisation de celles-ci Withdrawn EP1549951A4 (fr)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US38479802P	2002-05-30	2002-05-30
US384798P		2002-05-30
US40240702P	2002-08-09	2002-08-09
US402407P		2002-08-09
US44306203P	2003-01-28	2003-01-28
US443062P		2003-01-28
US10/403,676 US20040029150A1 (en)	1999-03-09	2003-03-31	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US403676		2003-03-31
PCT/US2003/017412 WO2003102584A2 (fr)	2002-05-30	2003-05-30	Proteines de type semaphorine et methodes d'utilisation de celles-ci

Publications (2)

Publication Number	Publication Date
EP1549951A2 EP1549951A2 (fr)	2005-07-06
EP1549951A4 true EP1549951A4 (fr)	2006-08-09

Family

ID=29716299

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP03739026A Withdrawn EP1549951A4 (fr)	2002-05-30	2003-05-30	Proteines de type semaphorine et methodes d'utilisation de celles-ci

Country Status (5)

Country	Link
EP (1)	EP1549951A4 (fr)
JP (1)	JP2005528434A (fr)
AU (1)	AU2003245387A1 (fr)
CA (1)	CA2487939A1 (fr)
WO (1)	WO2003102584A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2671322A1 (fr) *	2005-12-02	2007-07-12	Regents Of The University Of Colorado	Compositions et methodes pour le traitement de problemes medicaux medies par l'actine au moyen d'un agent modulant l'actine
WO2008097503A2 (fr)	2007-02-02	2008-08-14	Biogen Idec Ma Inc.	Procédé visant à favoriser la myélinisation et la différentiation oligodendrocytaire

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000031252A1 (fr) *	1998-11-26	2000-06-02	MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.	Semaphorine humaine 6a-1(sema6a-1), gene implique dans des mecanismes de developpement et de regeneration neuronaux pendant l'apoptose, et son utilisation en tant que cible potentielle de medicaments
WO2000053742A2 (fr) *	1999-03-09	2000-09-14	Curagen Corporation	Polynucleotides et proteines codees par ceux-ci
US20030054514A1 (en) *	1999-03-09	2003-03-20	Shimkets Richard A.	Novel polynucleotides and proteins encoded thereby
WO2003085096A2 (fr) *	2002-04-01	2003-10-16	Curagen Corporation	Polypeptides therapeutiques, acides nucleiques les codant et leurs procedes d'utilisation

2003
- 2003-05-30 CA CA002487939A patent/CA2487939A1/fr not_active Abandoned
- 2003-05-30 AU AU2003245387A patent/AU2003245387A1/en not_active Abandoned
- 2003-05-30 EP EP03739026A patent/EP1549951A4/fr not_active Withdrawn
- 2003-05-30 JP JP2004509418A patent/JP2005528434A/ja active Pending
- 2003-05-30 WO PCT/US2003/017412 patent/WO2003102584A2/fr not_active Ceased

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000031252A1 (fr) *	1998-11-26	2000-06-02	MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.	Semaphorine humaine 6a-1(sema6a-1), gene implique dans des mecanismes de developpement et de regeneration neuronaux pendant l'apoptose, et son utilisation en tant que cible potentielle de medicaments
WO2000053742A2 (fr) *	1999-03-09	2000-09-14	Curagen Corporation	Polynucleotides et proteines codees par ceux-ci
US20030054514A1 (en) *	1999-03-09	2003-03-20	Shimkets Richard A.	Novel polynucleotides and proteins encoded thereby
WO2003085096A2 (fr) *	2002-04-01	2003-10-16	Curagen Corporation	Polypeptides therapeutiques, acides nucleiques les codant et leurs procedes d'utilisation

Also Published As

Publication number	Publication date
CA2487939A1 (fr)	2003-12-11
JP2005528434A (ja)	2005-09-22
WO2003102584A2 (fr)	2003-12-11
WO2003102584A3 (fr)	2004-02-19
EP1549951A2 (fr)	2005-07-06
AU2003245387A1 (en)	2003-12-19

Similar Documents

Publication	Publication Date	Title
EP1501514A4 (fr)	2009-08-26	Modulateurs de proteine-kinases et leurs methodes d'utilisation
EP1546112A4 (fr)	2006-06-07	Imidazolopyridines, procedes de fabrication et methodes d'utilisation
EP1660013A4 (fr)	2011-07-20	Biomateriaux et biocoacervats proteiniques, leurs procedes de fabrication et d'utilisation
EP1549614A4 (fr)	2008-04-16	Agents vasculo-statiques et procedes d'utilisation de ceux-ci
AU2003217870A8 (en)	2003-09-16	Pini-modulating compounds and methods of use thereof
AU2003275311A1 (en)	2004-04-30	Solid micro-perforators and methods of use
EP1660638A4 (fr)	2009-02-18	Lipoparticules comprenant des proteines, et procedes de production et d'utilisation de ces lipoparticules
AU2003267124A8 (en)	2004-03-29	Bh3 peptides and method of use thereof
AU2003213673A8 (en)	2003-09-16	Pin1-modulating compounds and methods of use thereof
IL157142A0 (en)	2004-02-08	Modified antibodies and methods of use
PL376532A1 (pl)	2006-01-09	Pochodne podstawionych benzyloamin oraz sposoby wykorzystania
EP1648316A4 (fr)	2010-11-10	Dispositif de retenue et d'ecartement vertebral et son procede d'utilisation
AU2003224890A1 (en)	2003-10-27	Drug-complex microparticles and methods of making/using same
AU2003259717A8 (en)	2004-02-25	Modulators of rabggt and methods of use thereof
EP1578917A4 (fr)	2008-01-23	Proteines multimeres et methodes de production et d'utilisation de ces proteines
AU2003215244A8 (en)	2003-09-04	Complexes and methods of using same
AU2003297612A8 (en)	2004-06-23	2-substituted-3-propenamide derivatives and methods of using the same
AU2003252026A8 (en)	2004-02-09	Npc1l1 (npc3) and methods of use thereof
AU2003287802A1 (en)	2004-06-15	Palpometer and methods of use thereof
AU2003282338A8 (en)	2004-02-25	Determination of protein function
AU2003276844A8 (en)	2004-03-19	Formulations of modified antibodies and methods of making the same
AU2003216354A8 (en)	2003-09-09	Modulators of paraptosis and related methods
AU2002341828A1 (en)	2003-04-01	Enhanced proteins and methods for their use
AU2003222533A1 (en)	2003-11-17	Proteins with deglycating activities and methods of using same
EP1549951A4 (fr)	2006-08-09	Proteines de type semaphorine et methodes d'utilisation de celles-ci

Legal Events

Date	Code	Title	Description
2005-05-20	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2005-07-06	17P	Request for examination filed	Effective date: 20041130
2005-07-06	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
2005-07-06	AX	Request for extension of the european patent	Extension state: AL LT LV MK
2005-09-21	DAX	Request for extension of the european patent (deleted)
2005-11-16	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: CURAGEN CORPORATION
2006-02-08	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 38/16 20060101ALI20051221BHEP Ipc: C07K 14/47 20060101ALI20051221BHEP Ipc: C12N 15/62 20060101AFI20051221BHEP
2006-08-09	A4	Supplementary search report drawn up and despatched	Effective date: 20060706
2007-02-07	17Q	First examination report despatched	Effective date: 20070109
2007-12-07	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2008-01-09	18D	Application deemed to be withdrawn	Effective date: 20070720